Search research articles
Contact Us
Filters
Showing results (11-20 of 33) with videos related to
Page
of 4
Sort By:
American Journal of Hematology
|
January 1, 1991
Effective therapy of human immunodeficiency virus-associated anemia with recombinant human erythropoietin despite high endogenous erythropoietin
N A DaCosta, M B Hultin
Blood
|
November 1, 1981
Combined factor V-VIII deficiency: a case report with studies of factor V and VIII activation by thrombin
M B Hultin, M E Eyster
American Journal of Hematology
|
January 1, 1990
Postoperative thrombocytopenia in type IIB von Willebrand disease
M B Hultin, I I Sussman
Thrombosis and Haemostasis
|
June 16, 1988
Antithrombin Oslo: type Ib classification of the first reported antithrombin-deficient family, with a review of hereditary antithrombin variants
M B Hultin, J McKay, U Abildgaard
Thrombosis Research
|
December 1, 1992
Dibucaine elicits platelet procoagulant activity in factor VIII and factor X activation by a mechanism involving a sulfhydryl-dependent enzyme
M B Hultin, J Hennessey, S A Morrison
Blood
|
April 1, 1985
Altered factor VII activity in hemophilia
B C Miller, M B Hultin, J Jesty
The American Journal of Medicine
|
February 1, 1979
Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in renal failure
R P Warrell, M B Hultin, B S Coller
The Journal of Laboratory and Clinical Medicine
|
April 1, 1988
Factor VII activity state in coronary artery disease
C Hoffman, A Shah, M Sodums, et al.
American Journal of Hematology
|
May 1, 1989
Controlled prospective study of factor IX concentrate therapy and immunodeficiency
M B Hultin, R J Dattwyler, R A Lipton
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology
|
March 1, 1992
Correlation of factor VII activity and antigen with cholesterol and triglycerides in healthy young adults
C J Hoffman, R H Miller, M B Hultin
Page
of 4
Search research articles
Search
Showing results (11-20 of 33) with videos related to
Sort By:
Page
of 4
American Journal of Hematology
|
January 1, 1991
Effective therapy of human immunodeficiency virus-associated anemia with recombinant human erythropoietin despite high endogenous erythropoietin
N A DaCosta, M B Hultin
Blood
|
November 1, 1981
Combined factor V-VIII deficiency: a case report with studies of factor V and VIII activation by thrombin
M B Hultin, M E Eyster
American Journal of Hematology
|
January 1, 1990
Postoperative thrombocytopenia in type IIB von Willebrand disease
M B Hultin, I I Sussman
Thrombosis and Haemostasis
|
June 16, 1988
Antithrombin Oslo: type Ib classification of the first reported antithrombin-deficient family, with a review of hereditary antithrombin variants
M B Hultin, J McKay, U Abildgaard
Thrombosis Research
|
December 1, 1992
Dibucaine elicits platelet procoagulant activity in factor VIII and factor X activation by a mechanism involving a sulfhydryl-dependent enzyme
M B Hultin, J Hennessey, S A Morrison
Blood
|
April 1, 1985
Altered factor VII activity in hemophilia
B C Miller, M B Hultin, J Jesty
The American Journal of Medicine
|
February 1, 1979
Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in renal failure
R P Warrell, M B Hultin, B S Coller
The Journal of Laboratory and Clinical Medicine
|
April 1, 1988
Factor VII activity state in coronary artery disease
C Hoffman, A Shah, M Sodums, et al.
American Journal of Hematology
|
May 1, 1989
Controlled prospective study of factor IX concentrate therapy and immunodeficiency
M B Hultin, R J Dattwyler, R A Lipton
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology
|
March 1, 1992
Correlation of factor VII activity and antigen with cholesterol and triglycerides in healthy young adults
C J Hoffman, R H Miller, M B Hultin
Page
of 4